Insmed Inc. buy Truist Financial Co.
Start price
20.12.25
/
50%
€148.00
Target price
20.12.26
-
Performance (%)
-27.82%
Price
21.08.26
€106.82
Summary
This prediction is currently active. The price of Insmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.82%. This prediction currently runs until 20.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 0.131% | 0.131% |
| iShares Core DAX® | -1,28 % | 4,21 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % |
| iShares S&P 500 | -2,31 % | -0,10 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat